Xeris Biopharma Holdings Inc
LSE:0A8E
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Xeris Biopharma Holdings Inc
LSE:0A8E
|
US |
|
PCI- PAL PLC
LSE:PCIP
|
UK |
|
NCC Ltd
BSE:500294
|
IN |
|
K'S Holdings Corp
F:KSD
|
JP |
|
OC Oerlikon Corporation AG Pfaeffikon
OTC:OERLY
|
CH |
|
Abb Ltd
SIX:ABBN
|
CH |
|
Tilaknagar Industries Ltd
BSE:507205
|
IN |
|
Minor International PCL
OTC:MINOF
|
TH |
|
Smith & Nephew PLC
F:NPW1
|
UK |
|
M
|
Mitsubishi UFJ Financial Group Inc
DUS:MFZ
|
JP |
|
Windfall Geotek Inc
XTSX:WIN
|
CA |
|
B
|
Bic Camera Inc
F:1U3
|
JP |
|
B
|
BayWa AG
DUS:BYW6
|
DE |
|
Comcast Corp
NASDAQ:CMCSV
|
US |
|
Dynamatic Technologies Ltd
NSE:DYNAMATECH
|
IN |
|
A
|
Air China Ltd
XBER:AD2
|
CN |
|
Agenus Inc
F:AJ8
|
US |
|
S
|
Simcorp A/S
F:XCL1
|
DK |
Shareholder Yield
Current shareholder yield for 
0A8E is
hidden
.
Peers Comparison
Shareholder Yield
Buybacks
Buyback Yield measures how much a company reduces its outstanding shares through repurchases, expressed as a percentage.
This metric directly reflects the company’s efforts to return value to shareholders. By reducing the number of shares, buybacks can increase earnings per share and potentially boost the stock's price.
Peers Comparison
Buybacks
Debt Paydown
Debt Paydown Yield measures the amount of debt a company repays within a specific period, shown as a percentage of its market capitalization.
This metric indicates how the company is using its capital to decrease financial liabilities, which can strengthen its financial health and potentially enhance shareholder value.
Peers Comparison
Debt Paydown
Price Appreciation
0A8E Price
Xeris Biopharma Holdings Inc
| Average Annual Return |
N/A
|
| Standard Deviation of Annual Returns |
N/A
|
| Max Drawdown | -36% |
| Market Capitalization | 1B USD |
| Shares Outstanding | 165 920 000 |
| Percentage of Shares Shorted |
N/A
|
